Perinatal testing programs have two main purposes:
- Detect the presence of any IgG antibody (at an early stage in pregnancy) that could cause HDFN in order to identify, monitor, and treat the infant as soon as possible.
- Determine which patients are candidates for RhIg to prevent the production of anti-D.
